← Eichor
Study identifier: NCT07172347 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

Condition: Non-segmental Vitiligo  ·  Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

PhasePhase 2
Planned participants120
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study

This description comes directly from the study's public registry record.

Talk to the study team

xiaojuan lai  ·  15358160458  ·  lai_xiaojuan@vcarepharmatech.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Peking University People's HospitalBeijing, Beijng, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07172347